Noninvasive prenatal screening for fetal sex chromosome aneuploidies.
Cechuan DengSau Wai CheungHongqian LiuPublished in: Expert review of molecular diagnostics (2021)
Looking forward, NIPS is expected to become the primary screening test for common aneuploidies as well as other chromosome abnormalities, including some micro-deletions and micro-duplications, with the potential to transition from a screening test to a prenatal diagnosis method. Ultimately, the goal is to provide a safe and accurate method for increasing early diagnosis to improve long-term outcomes for the SCA patients and families by well- informed health care providers.